China's first domestically developed anti-HIV drug to go global

0 太阳城申博开户Print E-mail Xinhua, March 23, 2021
Adjust font size:

China's first domestically developed drug for the treatment of HIV infection has been approved by the health authority of Ecuador to access the country's market, according to pharmaceutical producer Frontier Biotech.

Aikening, or albuvirtide for injection (ABT), was approved by China Food and Drug Administration in 2018. It can be used with other antiretroviral drugs to treat HIV patients, according to Frontier Biotech, which is based in the east Chinese city of Nanjing.

The market access to Ecuador is the new drug's first overseas market entry.

Data from clinical trials show that Aikening is effective against major strains of HIV, including resistant viruses, and the efficacy is long-lasting.

The Chinese company said now it plans to export the drug to more than 60 countries in Asia, Africa, Europe and South America.

The global anti-HIV drug market grew from 22.9 billion U.S. dollars in 2013 to 34 billion U.S. dollars in 2018, and is expected to further expand to 46.7 billion U.S. dollars by 2023. 

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:    
    Racist, abusive and off-topic comments may be removed by the moderator.
网站地图 百家乐登入网址 太阳城手机版 777老虎机游戏登入 申博手机版
太阳城会员登入 申博网址 菲律宾申博开户 www.360msc.com
太阳城亚洲 申博娱乐手机版 太阳城登入 777老虎机游戏
申博手机下载版 澳门银河赌场 百家乐 申博百家乐
菲律宾太阳城申博 澳门银河赌场 百家乐 极速百家乐